JB Chemicals & Pharmaceuticals Recommends Final Dividend of Rs. 9.30 Per Share for FY 2025-26
J.B. Chemicals & Pharmaceuticals Limited announced that its Board of Directors recommended a final dividend for the financial year 2025-26. The proposal was considered during the Board meeting held on May 11, 2026.The Board recommended a final dividend of Rs. 9.30 per equity share of face value of Re. 1.
The company stated that if this dividend is declared by the shareholders at the ensuing Annual General Meeting (AGM), the funds will be remitted within 30 days of the declaration.
The meeting of the Board of Directors where this proposal was considered commenced at 6:15 p.m. and concluded at 6:56 p.m.
The key details of the dividend recommendation are presented below:
| Parameter | Details |
|---|---|
| Company | JB Chemicals & Pharmaceuticals Limited |
| Dividend Type | Final Dividend |
| Financial Year | 2025-26 |
| Dividend Amount | Rs. 9.30 per share |
| Dividend Percentage | 930% |
| Face Value | Re. 1 |
| Remittance Timeline | Within 30 days of shareholder declaration at AGM |
JBCHEPHARM Stock Price Movement
JB Chemicals & Pharmaceuticals Limited shares edged higher to close at ₹2209.2 today, gaining 2.93% in after-hours trading. The stock’s strong performance saw it hit its 52-week high of ₹2224.9, supported by a considerable volume of 584,031 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.